Siouxland Regional Cancer Center
Hematology & Oncology
230 Nebraska St, Sioux City
Iowa, 51101-1733
712-252-0088 712-252-9404
Siouxland Regional Cancer Center is a Hematology & Oncology in Sioux City, Iowa. It is located at 230 Nebraska St, Sioux City and it's customer support contact number is 712-252-0088. The authorized person of Siouxland Regional Cancer Center is Ms. Krista J Mccullough who is Executive Director of this DME and her contact number is 712-252-9301. Siouxland Regional Cancer Center accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Siouxland Regional Cancer Center is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
DME Supplier Details:
Siouxland Regional Cancer Center type, location, contact phone number and fax are as below. Patients can directly walkin or can call on the below given customer support phone number for enquiries.
| Name: | Siouxland Regional Cancer Center |
| Type: | Hematology & Oncology |
| Location: | 230 Nebraska St, Sioux City,
Iowa, 51101-1733 |
| Phone: | 712-252-0088 |
| Fax: | 712-252-9404 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this supplier is as below. Person's position and contact details are also mentioned below.
| Name: | Ms. Krista J Mccullough |
| Position: | Executive Director |
| Contact Number: | 712-252-9301 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given supplier are as mentioned below.
| NPI Number: | 1114904604 |
| NPI Enumeration Date: | 27 Dec, 2005 |
| NPI Last Update On: | 24 Jun, 2019 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Siouxland Regional Cancer Center are as mentioned below.
| Specialization | License Number | State | Status | |
| Hematology & Oncology | | | Primary | |
| Radiation Oncology | | | Secondary | |
| Durable Medical Equipment & Medical Supplies | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of this supplier such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 0460568 | Medicaid | Iowa | |
| 10025264400 | Medicaid | Nebraska | |
| 50928 | Other | Iowa | Wellmark |
Medicare Enrollment:
Siouxland Regional Cancer Center is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 9830148188 | O20050721000823 | Siouxland Regional Cancer Center | PART B SUPPLIER - CLINIC/GROUP PRACTICE |
| 9830148188 | O20150326002268 | Siouxland Regional Cancer Center | DME SUPPLIER - MULTI-SPECIALTY - PHYSICIAN |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box 5017,
Sioux City, Iowa |
| Zip: | 51102-5017 |
| Phone Number: | 712-252-9301 |
| Fax Number: | 712-252-9337 |
Patients can reach Siouxland Regional Cancer Center at
230 Nebraska St, Sioux City, Iowa or can
call on customer care at 712-252-0088.
Comments/ Reviews:
Read all the reviews posted for Siouxland Regional Cancer Center below. You may also share your own experience with Siouxland Regional Cancer Center. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 February, 2026.